117 related articles for article (PubMed ID: 30547888)
1. Elevated adiponectin and sTNFRII serum levels can predict progression to hepatocellular carcinoma in patients with compensated HCV1 cirrhosis.
Bastard JP; Fellahi S; Audureau É; Layese R; Roudot-Thoraval F; Cagnot C; Mahuas-Bourcier V; Sutton A; Ziol M; Capeau J; Nahon P;
Eur Cytokine Netw; 2018 Sep; 29(3):112-120. PubMed ID: 30547888
[TBL] [Abstract][Full Text] [Related]
2. Increased serum reverse triiodothyronine levels at diagnosis of hepatocellular carcinoma in patients with compensated HCV-related liver cirrhosis.
Sorvillo F; Mazziotti G; Carbone A; Morisco F; Cioffi M; Rotondi M; Stornaiuolo G; Amato G; Gaeta GB; Caporaso N; Carella C
Clin Endocrinol (Oxf); 2003 Feb; 58(2):207-12. PubMed ID: 12580937
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of heat shock protein HSP90AA1 and translocase of the outer mitochondrial membrane TOM34 in HCV-induced hepatocellular carcinoma: A pilot study.
Toraih EA; Alrefai HG; Hussein MH; Helal GM; Khashana MS; Fawzy MS
Clin Biochem; 2019 Jan; 63():10-17. PubMed ID: 30521791
[TBL] [Abstract][Full Text] [Related]
4. Serum miRNA-27a and miRNA-18b as potential predictive biomarkers of hepatitis C virus-associated hepatocellular carcinoma.
Rashad NM; El-Shal AS; Shalaby SM; Mohamed SY
Mol Cell Biochem; 2018 Oct; 447(1-2):125-136. PubMed ID: 29455432
[TBL] [Abstract][Full Text] [Related]
5. Influence of hepatitis C virus infection on circulating levels of sICAM-1 and VEGF in patients with hepatitis C and hepatocellular carcinoma (HCC) and their role in enhancing detection of HCC.
Helaly GF; Abou Shamaa LA
Egypt J Immunol; 2006; 13(1):27-38. PubMed ID: 17974148
[TBL] [Abstract][Full Text] [Related]
6. Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients.
Motawi TK; Shaker OG; El-Maraghy SA; Senousy MA
PLoS One; 2015; 10(9):e0137706. PubMed ID: 26352740
[TBL] [Abstract][Full Text] [Related]
7. Plasma adipokines and risk of hepatocellular carcinoma in chronic hepatitis B virus-infected carriers: a prospective study in taiwan.
Chen CL; Yang WS; Yang HI; Chen CF; You SL; Wang LY; Lu SN; Liu CJ; Kao JH; Chen PJ; Chen DS; Chen CJ
Cancer Epidemiol Biomarkers Prev; 2014 Aug; 23(8):1659-71. PubMed ID: 24895413
[TBL] [Abstract][Full Text] [Related]
8. Assessment of serum adiponectin in Egyptian patients with HCV-related cirrhosis and hepatocellular carcinoma.
Hamdy K; Al Swaff R; Hussein HA; Gamal M
J Endocrinol Invest; 2015 Nov; 38(11):1225-31. PubMed ID: 26359143
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study.
Bruno S; Silini E; Crosignani A; Borzio F; Leandro G; Bono F; Asti M; Rossi S; Larghi A; Cerino A; Podda M; Mondelli MU
Hepatology; 1997 Mar; 25(3):754-8. PubMed ID: 9049231
[TBL] [Abstract][Full Text] [Related]
10. Validation of a serum microRNA panel as biomarkers for early diagnosis of hepatocellular carcinoma post-hepatitis C infection in Egyptian patients.
Elemeery MN; Badr AN; Mohamed MA; Ghareeb DA
World J Gastroenterol; 2017 Jun; 23(21):3864-3875. PubMed ID: 28638226
[TBL] [Abstract][Full Text] [Related]
11. Insulin resistance, serum leptin, and adiponectin levels and outcomes of viral hepatitis C cirrhosis.
Nkontchou G; Bastard JP; Ziol M; Aout M; Cosson E; Ganne-Carrie N; Grando-Lemaire V; Roulot D; Capeau J; Trinchet JC; Vicaut E; Beaugrand M
J Hepatol; 2010 Nov; 53(5):827-33. PubMed ID: 20728234
[TBL] [Abstract][Full Text] [Related]
12. The Possible Role of Adipokines in HCV Associated Hepatocellular Carcinoma.
El-Daly UM; Saber MM; Abdellateif MS; Nassar HR; Namour AE; Ismail YM; Zekri AN
Asian Pac J Cancer Prev; 2020 Mar; 21(3):599-609. PubMed ID: 32212784
[TBL] [Abstract][Full Text] [Related]
13. Total and high molecular weight adiponectin and hepatocellular carcinoma with HCV infection.
Sumie S; Kawaguchi T; Kuromatsu R; Takata A; Nakano M; Satani M; Yamada S; Niizeki T; Torimura T; Sata M
PLoS One; 2011; 6(11):e26840. PubMed ID: 22110596
[TBL] [Abstract][Full Text] [Related]
14. Alcohol intake increases the risk of HCC in hepatitis C virus-related compensated cirrhosis: A prospective study.
Vandenbulcke H; Moreno C; Colle I; Knebel JF; Francque S; Sersté T; George C; de Galocsy C; Laleman W; Delwaide J; Orlent H; Lasser L; Trépo E; Van Vlierberghe H; Michielsen P; van Gossum M; de Vos M; Marot A; Doerig C; Henrion J; Deltenre P
J Hepatol; 2016 Sep; 65(3):543-51. PubMed ID: 27180899
[TBL] [Abstract][Full Text] [Related]
15. Circulating visfatin level is associated with hepatocellular carcinoma in chronic hepatitis B or C virus infection.
Tsai IT; Wang CP; Yu TH; Lu YC; Lin CW; Lu LF; Wu CC; Chung FM; Lee YJ; Hung WC; Hsu CC
Cytokine; 2017 Feb; 90():54-59. PubMed ID: 27770715
[TBL] [Abstract][Full Text] [Related]
16. Plasma protein biomarkers of hepatocellular carcinoma in HCV-infected alcoholic patients with cirrhosis.
Ferrín G; Rodríguez-Perálvarez M; Aguilar-Melero P; Ranchal I; Llamoza C; Linares CI; González-Rubio S; Muntané J; Briceño J; López-Cillero P; Montero-Álvarez JL; de la Mata M
PLoS One; 2015; 10(3):e0118527. PubMed ID: 25789864
[TBL] [Abstract][Full Text] [Related]
17. Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis.
Stroffolini T; Almasio PL; Persico M; Bollani S; Benvegnù L; Di Costanzo G; Pastore G; Aghemo A; Stornaiuolo G; Mangia A; Andreone P; Stanzione M; Mazzella G; Saracco G; Del Poggio P; Bruno S;
Am J Gastroenterol; 2008 Aug; 103(8):1966-72. PubMed ID: 18637087
[TBL] [Abstract][Full Text] [Related]
18. Serum MicroRNA-122 and MicroRNA-155: Markers of Disease Progression in Hepatitis C viral infection.
Sheneef A; Gouda AM; Mohammad AN; Yousef LM; Noureldin AK
Egypt J Immunol; 2017 Jun; 24(2):33-46. PubMed ID: 29528577
[TBL] [Abstract][Full Text] [Related]
19. Plasma Adiponectin and Hepatocellular Carcinoma Survival Among Patients Without Liver Transplantation.
Shen J; Yeh CC; Wang Q; Gurvich I; Siegel AB; Santella RM
Anticancer Res; 2016 Oct; 36(10):5307-5314. PubMed ID: 27798893
[TBL] [Abstract][Full Text] [Related]
20. Improved survival of patients with hepatocellular carcinoma and compensated hepatitis C virus-related cirrhosis who attained sustained virological response.
Bruno S; Di Marco V; Iavarone M; Roffi L; Boccaccio V; Crosignani A; Cabibbo G; Rossi S; Calvaruso V; Aghemo A; Giacomelli L; Craxì A; Colombo M; Maisonneuve P
Liver Int; 2017 Oct; 37(10):1526-1534. PubMed ID: 28418617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
